Clinical Trial Update: KRDI in Transplant-Eligible MM [Phase 2]

View source ↗

Summary

A Phase 2 study of KRDI in transplant-eligible multiple myeloma has posted results and the trial remains active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• KRDI

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-26